In the Original Investigation by Ignatiadis et al titled “The Genomic Grade Assay Compared with Ki67 to Determine Risk of Distant Breast Cancer Recurrence,” published online December 3, 2015, and in the February 2016 print issue of JAMA Oncology,1 the colors in the legends for Figures 2 (panels B and C) and 3 (panel B) were inverted. This article was corrected online.
1.Ignatiadis
M, Azim
HA
Jr, Desmedt
C,
et al. The genomic grade assay compared with Ki67 to determine risk of distant breast cancer recurrence.
JAMA Oncol. 2016;2(2):217-224.
PubMedGoogle ScholarCrossref